175 related articles for article (PubMed ID: 33001492)
1. Driving performance and neurocognitive skills of long-term users of sedating antidepressants.
van der Sluiszen NNJJM; Vermeeren A; van Dijken JH; J A E van de Loo A; Veldstra JL; de Waard D; C Verster J; A Brookhuis K; Ramaekers JG
Hum Psychopharmacol; 2021 Jan; 36(1):1-12. PubMed ID: 33001492
[TBL] [Abstract][Full Text] [Related]
2. Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics.
van der Sluiszen NNJJM; Vermeeren A; Verster JC; van de Loo AJAE; van Dijken JH; Veldstra JL; Brookhuis KA; de Waard D; Ramaekers JG
Hum Psychopharmacol; 2019 Nov; 34(6):e2715. PubMed ID: 31837049
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
Ramaekers JG
J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
[TBL] [Abstract][Full Text] [Related]
5. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
[TBL] [Abstract][Full Text] [Related]
6. A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L.
Jongen S; Vermeeren A; van der Sluiszen NN; Schumacher MB; Theunissen EL; Kuypers KP; Vuurman EF; Ramaekers JG
Psychopharmacology (Berl); 2017 Mar; 234(5):837-844. PubMed ID: 28070617
[TBL] [Abstract][Full Text] [Related]
7. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.
Schumacher MB; Jongen S; Knoche A; Petzke F; Vuurman EF; Vollrath M; Ramaekers JG
Psychopharmacology (Berl); 2017 Mar; 234(6):989-999. PubMed ID: 28190085
[TBL] [Abstract][Full Text] [Related]
9. Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.
Vinckenbosch FRJ; Vermeeren A; Verster JC; Ramaekers JG; Vuurman EF
Psychopharmacology (Berl); 2020 Mar; 237(3):877-886. PubMed ID: 31897572
[TBL] [Abstract][Full Text] [Related]
10. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
[TBL] [Abstract][Full Text] [Related]
11. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
12. An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.
Vinckenbosch FRJ; Vermeeren A; Vuurman EFPM; van der Sluiszen NNJJM; Verster JC; van de Loo AJAE; van Dijken JH; Veldstra JL; Brookhuis KA; De Waard D; Ramaekers JG
Hum Psychopharmacol; 2021 Jul; 36(4):e2778. PubMed ID: 33547849
[TBL] [Abstract][Full Text] [Related]
13. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
[TBL] [Abstract][Full Text] [Related]
14. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
[TBL] [Abstract][Full Text] [Related]
15. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
16. Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.
Iwata M; Iwamoto K; Kitajima I; Nogi T; Onishi K; Kajiyama Y; Nishino I; Ando M; Ozaki N
Psychopharmacology (Berl); 2021 Mar; 238(3):775-786. PubMed ID: 33236169
[TBL] [Abstract][Full Text] [Related]
17. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
18. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
19. On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.
van der Sluiszen NN; Vermeeren A; Jongen S; Theunissen EL; van Oers AC; Van Leeuwen CJ; Maret A; Desforges C; Delarue A; Ramaekers JG
Psychopharmacology (Berl); 2016 Sep; 233(18):3461-9. PubMed ID: 27488192
[TBL] [Abstract][Full Text] [Related]
20. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
Brunnauer A; Laux G; David I; Fric M; Hermisson I; Möller HJ
J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
